Clinical Trial Supplies Market To Reach $10.7 Billion By 2033

Clinical Trial Supplies Market Growth & Trends

The global clinical trial supplies market size is estimated to reach USD 10.7 billion in 2033 and is anticipated to grow at a CAGR of 8.4% from 2026 to 2033, according to a new report by Grand View Research, Inc. Increasing volume of clinical trial studies coupled with the growing complexity in conduction of these trials are some of the major factors driving the market growth.

Globally, an increase in the prevalence of chronic diseases and the rapidly aging population are expected to drive the growth of R&D of biologics, which is expected to further propel the demand for efficient clinical supplies and contribute to the growth of the clinical trial supplies industry. Furthermore, an increase in the demand for orphan drugs and high investment in the R&D of rare diseases are also expected to contribute toward the development of biologic drugs. Thus, owing to these factors, this segment is likely to witness significant growth during the forecast period.

For instance, in 2022, Novartis invested around USD 10 billion in research and development. It also secured 23 approvals in the European Union, Japan, China, and the U.S. for new drugs and rare diseases. The company is also conducting 44 ongoing phase III programs in India with 17 clinical programs running in rare diseases such as atypical hemolytic uremic syndrome (aHUS), Immune thrombocytopenic purpura (ITP), spinal muscular atrophy (SMA), and Lupus Nephritis.

Direct-to-Patients (DTP) is an upcoming segment in the distribution of clinical trial supplies, which is expected to be the future model of distribution. DTP is one of the emerging models that involves delivering drugs to patients directly to create patient-centric trials. This would facilitate fewer visits to the site and reduce the burden on participants. The COVID-19 outbreak has led to the increased adoption of such a model, to continue clinical trial studies with minimum disruption. In addition, patient retention and a diverse pool of patients worldwide are some of the notable reasons that can be attributed to the high adoption of this model.

 Request a free sample copy or view report summary: Clinical Trial Supplies Market Report

Clinical Trial Supplies Market Report Highlights

• Based on the clinical phase segment, the phase III segment dominated the market in 2025, accounting for a revenue share of 53.1%. The growth is driven by large patient enrollment, longer study timelines, and highly complex logistical requirements.

• The supply chain management segment accounted for the largest revenue share in 2025. The segment growth is driven by the growing complexity of multinational clinical trials and the need for streamlined logistics operations.

• Pharmaceutical accounted for the largest revenue share in 2025, owing to rising R&D investments, expansion of biologics and personalized medicine pipelines, and increasing outsourcing of clinical supply operations.

• Based on therapeutic area, the oncology segment dominated the market with the largest revenue share in 2025. The segment’s growth is due to rising cancer prevalence, expanding oncology trial activity, and increasing demand for biologics and immunotherapies.

Clinical Trial Supplies Market Segmentation

Grand View Research has segmented the global clinical trial supplies market based on product, service, phase, therapeutic area, and region: 

Clinical Trial Supplies Phase Outlook (Revenue, USD Million, 2021 - 2033)

• Phase I

• Phase II

• Phase III

• Others

Clinical Trial Supplies Service Outlook (Revenue, USD Million, 2021 - 2033)

• Manufacturing

• Storage & Distribution

  • Cold Chain

  • Non-cold Chain

• Supply Chain Management

Clinical Trial Supplies Product Outlook (Revenue, USD Million, 2021 - 2033)

• Pharmaceutical

• Biologics

• Medical device

• Others

Clinical Trial Supplies Therapeutic Area Outlook (Revenue, USD Million, 2021 - 2033)

• Oncology

• CNS Diseases

• Cardiovascular Diseases

• Infectious Diseases

• Metabolic Disorders

• Others

Clinical Trial Supplies Regional Outlook (Revenue, USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • Thailand

  • South Korea

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • UAE

  • Saudi Arabia

  • Kuwait

  • Qatar

  • Oman

List of Key Players in Clinical Trial Supplies Market

• Almac Group

• Biocair

• Catalent Inc.

• KLIFO

• Movianto

• PCI Pharma Services

• Sharp Services, LLC

• Thermo Fischer Scientific Inc.

• United Parcel Service of America, Inc (UPS Healthcare)

• Parexel International Corporation